Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,120 | 2 | 49.6% |
| Consulting Fee | $2,485 | 2 | 24.1% |
| Honoraria | $1,800 | 1 | 17.5% |
| Food and Beverage | $908.44 | 7 | 8.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $5,888 | 9 | $0 (2023) |
| Amgen Inc. | $2,000 | 1 | $0 (2022) |
| Pfizer Inc. | $1,800 | 1 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $625.00 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $625.00 | 1 | Novartis Pharmaceuticals Corporation ($625.00) |
| 2023 | $3,513 | 4 | JAZZ PHARMACEUTICALS INC. ($3,513) |
| 2022 | $2,000 | 1 | Amgen Inc. ($2,000) |
| 2021 | $1,860 | 1 | JAZZ PHARMACEUTICALS INC. ($1,860) |
| 2020 | $1,800 | 1 | Pfizer Inc. ($1,800) |
| 2019 | $253.41 | 2 | JAZZ PHARMACEUTICALS INC. ($253.41) |
| 2018 | $262.15 | 2 | Jazz Pharmaceuticals Inc. ($262.15) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/08/2024 | Novartis Pharmaceuticals Corporation | KYMRIAH (Drug) | Consulting Fee | Cash or cash equivalent | $625.00 | General |
| Category: Oncology | ||||||
| 12/18/2023 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,120.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/10/2023 | JAZZ PHARMACEUTICALS INC. | — | Food and Beverage | In-kind items and services | $147.01 | General |
| 12/09/2023 | JAZZ PHARMACEUTICALS INC. | — | Food and Beverage | In-kind items and services | $146.32 | General |
| 12/08/2023 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Food and Beverage | In-kind items and services | $99.55 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/03/2022 | Amgen Inc. | Blincyto (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Oncology | ||||||
| 01/18/2021 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Consulting Fee | Cash or cash equivalent | $1,860.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/05/2020 | Pfizer Inc. | BESPONSA (Biological) | Honoraria | Cash or cash equivalent | $1,800.00 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2019 | JAZZ PHARMACEUTICALS INC. | ERWINAZE (Drug) | Food and Beverage | In-kind items and services | $125.18 | General |
| Category: ONCOLOGY | ||||||
| 03/13/2019 | JAZZ PHARMACEUTICALS INC. | DEFITELIO (Drug) | Food and Beverage | In-kind items and services | $128.23 | General |
| Category: HEMATOLOGY | ||||||
| 10/03/2018 | Jazz Pharmaceuticals Inc. | Erwinaze (Drug), Defitelio | Food and Beverage | In-kind items and services | $126.80 | General |
| Category: Oncology | ||||||
| 04/11/2018 | Jazz Pharmaceuticals Inc. | Defitelio (Drug), Erwinaze | Food and Beverage | In-kind items and services | $135.35 | General |
| Category: Hematology | ||||||
About Stacy Cooper
Stacy Cooper is a Pediatric Hematology-Oncology healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2008. The National Provider Identifier (NPI) number assigned to this provider is 1013182963.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stacy Cooper has received a total of $10,313 in payments from pharmaceutical and medical device companies, with $625.00 received in 2024. These payments were reported across 12 transactions from 4 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($5,120).
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Baltimore, MD
- Active Since 04/22/2008
- Last Updated 09/09/2021
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1013182963
Products in Payments
- RYLAZE (Drug) $5,080
- Blincyto (Biological) $2,000
- BESPONSA (Biological) $1,800
- KYMRIAH (Drug) $625.00
- Defitelio (Drug) $135.35
- DEFITELIO (Drug) $128.23
- Erwinaze (Drug) $126.80
- ERWINAZE (Drug) $125.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Baltimore
Ido Paz Priel, M.d, M.D
Pediatric Hematology-Oncology — Payments: $28,344
Heather Symons, M.d, M.D
Pediatric Hematology-Oncology — Payments: $23,334
Jennifer Keates-Baleeiro, Md, MD
Pediatric Hematology-Oncology — Payments: $2,915
Dr. Challice Bonifant, Md, Phd, MD, PHD
Pediatric Hematology-Oncology — Payments: $1,500
Dr. Yoram Unguru, M.d., M.s., M.a, M.D., M.S., M.A
Pediatric Hematology-Oncology — Payments: $1,275
Miss. Beth Carella, D.o, D.O
Pediatric Hematology-Oncology — Payments: $905.57